Phase 3 Committee

Membership 2008

Membership is for a period of two years. The Presiding Member of the committee will be invited to become a member of the CDC.

Presiding Member - (to be elected by the Committee)	Associate Professor Phil Jones
Associate Dean, Education (ex officio)	Associate Professor Phil Jones
Course convenors for each Phase 3 course
	Dr Shing Wong
	Dr Colleen Loo
	Dr Barbara Booth
	Dr Ian Andrews
	Dr Antony Lighten
Convenor of Phase 3 Biomedical Sciences program	Dr Gary Velan
A representative from the clinical Learning and Assessment Committee	Associate Professor Phil Jones Dr Meredith Makeham
Additional members as suggested by the CDC to ensure broad representation on the committee from Schools reponsible for the administration of Phase 3, clinical disciplines and the social and biomedical sciences
- Emergency	Associate Professor Gordian Fulde
- Clinical Pharmacology & Toxicology	Professor Ric Day
- Quality Medical Practice (QMP)	Dr Rachel Thompson
- Rural Clinical School	Dr Lesley Forster
- St George Clinical School	Dr George Mangos
- St Vincent's Clinical School	Dr Rohan Gett
- St Vincent's Clinical School	Ms Naomi Esselbrugge
- South Western Sydney Clinical School	Dr Tim Spicer
- Sutherland Hospital Teaching Unit	Dr Greg Katsoulotos
Undergraduate Student Representatives	Mr Parth Shah Mr Cameron Korb-Wells
In Attendance
Representative of the Office of the Dean responsible for administration of Phase 3	Ms Petrina Choong
Secretarial Support
Office of Medical Education	Mr David Micallef

Formation

The Curriculum Development Committee (CDC) resolved at its meeting on April 2, 2003 to:
– form Phase Committees for Phases 1, 2 and 3 of the new Medicine program 3802, and
– that membership and roles of these committees will evolve over time,
– that members will be appointed by CDC, and
– that CDC will have an oversight role of the Phase Committees.

Functions

To continuously develop a framework or blueprint for the phase, which effectively integrates its component courses.
To review teaching, learning and assessment activities submitted by course convenors, to ensure that assessments are integrated and aligned with graduate capabilities and teaching activities; the phase committee will have the authority to accept or reject such activities for a course.
To convene groups to set assessments according to the requirements of the blueprint.
To develop standard-setting procedures and examiner training for portfolio marking.
To oversee the conduct and marking of assessments (assignments and projects), portfolio reviews and the training of examiners/markers.
To review evaluation and assessment data for the phase, and suggest modifications to content and design of teaching activities and assessment as appropriate.